Related Experiment Video
Updated: May 11, 2026

07:43
Endoscopic Endonasal Trans-sphenoidal Approach: Minimally Invasive Surgery for Pituitary Adenomas
Published on: January 17, 2018
Update on hypophysitis and TTF-1 expressing sellar region masses
Bette K Kleinschmidt-DeMasters1, M Beatriz S Lopes
1Department of Pathology, The University of Colorado School of Medicine, Aurora, CO, USA. bk.demasters@ucdenver.edu
Brain Pathology (Zurich, Switzerland)
|May 25, 2013
Summary
Diagnosing sellar region masses mimicking pituitary adenomas like hypophysitis and tumors requires tissue confirmation due to overlapping features. Recent literature and new hypophysitis types are discussed.
Area of Science:
- Endocrinology and Neurosurgery
- Pituitary Gland Disorders
- Sellar Region Mass Differential Diagnosis
Background:
- Nonsecretory pituitary adenomas are often mimicked by other sellar region masses, complicating clinical and radiological diagnosis.
- Accurate differentiation is crucial as these entities frequently require biopsy or surgical resection for definitive diagnosis.
- Recent literature has expanded understanding of hypophysitis and related neoplastic conditions.
Observation:
- Four entities—hypophysitis, pituicytoma, spindle cell oncocytoma, and granular cell tumor of the neurohypophysis—present diagnostic challenges.
- Distinguishing these masses preoperatively based on clinical or imaging features remains difficult.
- New forms of hypophysitis, including IgG4 plasma cell hypophysitis and therapy-induced hypophysitis, have been identified.
Findings:
- Immunohistochemical staining for thyroid transcription factor-1 (TTF-1) is common to pituicytoma, spindle cell oncocytoma, and granular cell tumor, suggesting a shared cell lineage.
- This shared lineage explains the histological overlap observed between these neoplastic conditions.
- Review incorporates 30 years of experience from specialized pituitary mass centers.
Implications:
- Accurate pathological diagnosis is essential for appropriate management of sellar region masses.
- Understanding shared markers like TTF-1 aids in classifying these tumors and differentiating them from hypophysitis.
- Continued research and clinical experience are vital for improving diagnostic accuracy and patient outcomes.
Related Concept Videos
Hyperthyroidism II: Pathophysiology
Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...
Graves Disease II: Pathophysiology
Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor, and heat...

